Unemo M, Ahlstrand J, Sanchez-Buso L, Day M, et al. High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018. J Antimicrob Chemother 2021;76:1221-1228.
PMID: 33564854